bismuth tripotassium dicitrate: Clinical Trials

4 trials of bismuth tripotassium dicitrate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Not yet recruiting 1, Recruiting 1

Follow bismuth tripotassium dicitrate: new trials by email Literature Review of bismuth tripotassium dicitrate trials Research Report on bismuth tripotassium dicitrate

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma
Esomeprazole, Bismuth tripotassium dicitrate, Tetracycline, and Metronidazole - MALT Lymphoma of Stomach
Phase 2Not yet recruitingNational Taiwan University Hospital402025-09-012025-08-27
Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
Oxaliplatin With S-1 (SOX) Combined H. Pylori Eradication (Amoxicillin + clarithromycin + omeprazole + colloidal bismuth subcitrate), Oxaliplatin With S-1 (SOX) - Chemotherapy Effect
Phase 2RecruitingSixth Affiliated Hospital, Sun Yat-sen University1982024-12-312026-08-06
The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease
H.pylori eradication (Omeprazole, Amoxicillin, Bismuth subcitrate, Azithromycin) - Fatty Liver, Liver Dysfunction
Phase 2CompletedTehran University of Medical Sciences1002012-07-012013-07-08
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
bismuth subcitrate, amoxicillin, clarithromycin - Lymphoma
Phase 2CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC961997-09-012012-07-02

Conditions studied

Lymphoma, B-Cell, Marginal Zone (2)  ·  Digestive System Diseases (1)  ·  Fatty Liver (1)  ·  Insulin Resistance (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Liver Diseases (1)  ·  Lymphoma (1)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  National Taiwan University Hospital (1)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (1)  ·  Tehran University of Medical Sciences (1)

Countries

China (1)  ·  Iran (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

John W. Sweetenham, MD (1)  ·  Lei Lian, Ph.D (1)  ·  Patrice P. Carde, MD (1)  ·  Raika Jamali, M.D. (1)